cvs-health
-
What CVS Stands to Gain by Setting Up Biosimilar Subsidiary Cordavis
Pharmaceutical industry observers say CVS Health’s creation of Cordavis, a new biosimilar drugs company, is part of a strategy to make its move into this market as profitable as possible.
-
CVS Health Exec: The Behavioral Health Industry Needs a ‘Common App’ for Insurance
There are a lot of administrative hurdles behavioral health providers have to go through to join an insurer’s network. That’s why the industry needs something similar to the “Common App” for applying to be in-network with insurers, said Cara McNulty, president of behavioral health and mental wellbeing at CVS Health. The Common App allows students to apply to multiple colleges through one application.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
CVS’ Shuttered Clinical Trials Business Doesn’t Mean Decentralized Models Are Doomed, Exec Says
CVS Health is winding down its clinical trials business, with a full exit expected by December 31, 2024, the company confirmed to MedCity News. But decentralized clinical trials still have an important role to play, said Brian Weiss, CEO of Carebox.
-
CVS Health: 60% of Mental Health Physicians See Patients’ Conditions Declining
New CVS Health data found that while 42% of respondents are concerned about their mental health, only 12% are seeing a mental health professional, such as a psychiatrist, psychologist, psychotherapist or wellbeing therapist. Younger respondents are especially struggling: 60% of those aged 18 to 32 years old are concerned about their mental health.
-
Does AI Have a Place in Behavioral Healthcare? Experts Weigh In
Artificial Intelligence shows great potential for behavioral healthcare, but it has a ways to go, said Taft Parsons III, vice president and chief psychiatric officer of CVS Health. He made these comments Tuesday at the HIMSS 2023 conference in Chicago.
-
Consumer / Employer, Health Tech
All Generations Find Telehealth Beneficial, New CVS Health Data Shows
A new CVS Health survey found that 76% of adults agree that telehealth is more convenient than other healthcare options. Additionally, 75% agree that it is more flexible, 75% believe that it is easier to schedule appointments and 77% said that it is quicker to provide care. The percentages varied slightly by generation, although a vast majority of each age group still said they agreed with these characteristics for telehealth.
-
Q&A: As Congressional Heat Builds on PBMs, What Is the Message From the Industry Lobby?
The largest six pharmacy benefit managers are being scrutinized by the Federal Trade Commission, while Congress is debating the Pharmacy Benefit Transparency Act. Meanwhile, states have their own ideas for reining in what they see as excesses of the industry. With all this heat, what is the message from the head of the Pharmaceutical Care Management Association?
-
Which Moves Should Providers Watch From Amazon, CVS & Walgreens This Year?
Analysts predict that disruptors could own as much as 30% of the $260 billion primary care market by 2030. A recent report from the American Hospital Association outlines major moves the healthcare industry should be watching this year from disruptors like Amazon, CVS and Walgreens — from billion-dollar acquisitions of primary care companies to expanding clinic locations to efforts in the home care space.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Will it? Won’t It? CVS Health To Finally Acquire Oak Street Health for $10.6B
Rumors of the deal first surfaced in January, with some dismissing the idea. Several experts say the deal makes sense for CVS Health, as it looks to expand into primary and value-based senior care.
-
6 Takeaways From the 41st J.P. Morgan Healthcare Conference
The 41st annual J.P. Morgan Healthcare Conference concluded last week. After the pandemic prompted it to go virtual, it was back in person, smaller in size and more effective. Here are my takeaways.
-
Consumer / Employer, Health Tech
CVS Health Makes Waves During JPM: Experts Weigh In
CVS Health announced investments this week in Carbon Health, Monogram Health and Array Behavioral Care. There have also been rumors that the company is exploring a $10 billion deal with primary care company Oak Street Health.
-
Consumer / Employer, Health Tech, SYN
CVS Invests $25M in Virtual Mental Health Clinic
CVS Health invested $25 million in Array Behavioral Care, a provider of virtual mental health care. Last year, Array’s clinicians had more than 400,000 encounters with patients.
-
All About Access: The Key Trends In Retailers’ Acquisitions in 2022
Whether it was Amazon’s buy of One Medical or CVS Health’s acquisition of Signify Health, retailers made waves in healthcare this year. Across all of the deals, it’s clear that expanding access to medical services is the key goal, experts said. And this is only the beginning.